TARA Protara Therapeutics Inc
Company Analysis
Latest News
🟢 Protara Therapeutics Inc is trading 5.1% up today after shareholders approve doubling authorized common stock
Protara Therapeutics Inc is trading 5.1% up at $4.00 after investors reacted to shareholder approval to increase the company's authorized common stock from 100...
Protara Doubles Its Share Ceiling — Is Management Quietly Loading the Gun for a Big Capital Raise?
Shares of Protara Therapeutics jumped 7.9% to $4.25 in pre-market trading after shareholders at the company's June 12 annual meeting voted overwhelmingly to...
🟢 Protara Therapeutics Inc is trading 7.9% up today after shareholders approved doubling authorized common stock
Protara Therapeutics Inc is trading 7.9% up at $4.25 in pre-market trading after investors reacted to news from the company's 2026 Annual Meeting. •...
Protara Therapeutics Shareholders Approve Doubling Authorized Common Stock to 200M
Protara Therapeutics announced the results of its 2026 Annual Meeting of Stockholders, where shareholders approved several key proposals, most notably an...
Protara Therapeutics Shares Fall Despite Positive Analyst Ratings
Protara Therapeutics (TARA) shares declined nearly 15% in after-hours trading on Friday, June 12, 2026. The stock had closed the regular session with a 9%...
🟢 Protara Therapeutics Inc is trading 5.9% up today as AGM visibility extends recent gains
Protara Therapeutics Inc is trading at $4.13 (+5.9%) in after-hours trading as investors continue to react to visibility and attention surrounding the...
🟢 Protara Therapeutics Inc is trading 5.1% up today amid its Annual General Meeting
Protara Therapeutics Inc is trading 5.1% up at $3.83 today as the company holds its Annual General Meeting, drawing investor attention despite a lack of new...